Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nolek Intressenter AB in connection with the sale of Nolek AB to Indutrade AB (publ.)
Mandate

Vinge advises Nolek Intressenter AB in connection with the sale of Nolek AB to Indutrade AB (publ.)

December 05, 2012

Vinge has advised Nolek Intressenter AB in connection with the sale of Nolek AB to Indutrade AB (publ.). Nolek is a leading producer of instruments and machines for leak testing, leak detection and proof testing. The company has production facilities in Sweden and Malaysia and sales companies in the US, Hungary and Denmark. The company’s customers include companies with international operations in a range of areas, including the automotive, pharmaceuticals, electronics and engineering industries.

Vinge’s team consisted of Jonas Bergström together with, among others, associates Alex Miler, Alexandra Kempe, Gustav Jönsson and Daniel Järmén as well as project assistant Sara Andersson.

Related

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025